WST•benzinga•
West Pharmaceutical Services Sees FY25 Adj. EPS $6.00-$6.20 vs. $7.44 Est., Revenue $2.875B-$2.905B vs. $3.042B Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga